Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
JENBURPH Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
High and stable ROE
High and stable operating margin
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low revenue growth and in line with median growth of industry
Neutral
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
Moderate dividend yield
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0636315.
Snapshot
See detailed analysis
JENBURPH Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
JENBURPH Bulk, Block & Insider Trades
JENBURPH Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Share Buyback"On Market Tender Offer. Total Amount Returned INR 119999808. Share Capital 22.37 percent Currently. Offer Price INR 576." Ex-date: 9th Nov 2017 Announced on: 30th Oct 2017
Company Profile
Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic a... Read More
Key personnel
Shri. Ashish U. BhutaD
Chairman, Managing Director
Shri. Dilip H. BhutaD
Whole Time Director, Chief Financial Officer
Shri. Ashish R. Shah
Compliance Officer, Company Secretary
Shri. Pankaj Arun DantwalaD
Additional Non-Executive Independent Director
Mrs. Hina Ravindra MehtaD
Non-Executive Independent Director
Shri. Krishnan SubharamanD
Additional Non-Executive Independent Director
Shri. Sumit Ajaybhai ThakkarD
Non-Executive Independent Director
Vijayan J. Pillai
Executive - Secretarial Dept.
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Jenburkt Pharmaceuticals Ltd.?
The current share price of Jenburkt Pharmaceuticals Ltd. is ₹ 1,095.65 as of 09 Jan 2026.
What is the PE ratio of Jenburkt Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Jenburkt Pharmaceuticals Ltd. is 14.65 as of the latest financial data.
What is the ROE and ROCE of Jenburkt Pharmaceuticals Ltd.?
Jenburkt Pharmaceuticals Ltd. has a Return on Equity (ROE) of 20.25% and a Return on Capital Employed (ROCE) of 23.50% as per the latest financial reports.
What is the market cap of Jenburkt Pharmaceuticals Ltd.?
The market capitalization of Jenburkt Pharmaceuticals Ltd. stands at ₹ 483.51 Cr.
What is the dividend yield of Jenburkt Pharmaceuticals Ltd.?
The dividend yield of Jenburkt Pharmaceuticals Ltd. is 1.64% based on the current market price.
What is the RSI of Jenburkt Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Jenburkt Pharmaceuticals Ltd. is 45.74.
What is the FII and DII holding in Jenburkt Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Jenburkt Pharmaceuticals Ltd. shares.
What sector does Jenburkt Pharmaceuticals Ltd. belong to?
Jenburkt Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Jenburkt Pharmaceuticals Ltd. stock?
The beta of Jenburkt Pharmaceuticals Ltd. stock is 0.83, indicating its volatility relative to the broader market.
